Barriers to appropriate HIV treatment and care for HIV-infected injection drug users (IDU) are a growing concern. International efforts to improve the delivery of highly active antiretroviral therapy (HAART) toIDU, such as the WHO'S 3 by 5 Initiative, are in urgent need of data on how these barriers can be addressed. While there has been much focus on HIV prevention for HIV-negative IDU, there has recently been a growing recognition that breaking the cycle of HIV transmission will require renewed focus on behaviors and prevention needs of HIV-infected IDU. This proposal seeks to fill the information gap existing in North America and elsewhere through the following specific aims: 1. To evaluate the incidence of HIV/AIDS service uptake (e.g., antiretroviral therapy) and factors associated with uptake among IDU 2. To evaluate the incidence of HIV antiretroviral drug resistance among HIV-infected IDU and the role of unique antiretroviral delivery models on the time to antiretroviral resistance 3. To evaluate trends in HIV disease progression and factors such as medical service and secondary prevention service use that may be associated with reduced disease progression among IDU 4. To determine factors associated with persistent HIV risk behaviors (e.g., syringe lending) in a setting with comprehensive evidence-based HIV prevention strategies for HIV-infected IDU These aims will be met through the development of a new prospective cohort study of HIV-infected IDU in Vancouver, Canada. This setting is unique, since all medical care and antiretrovirals are provided free of charge through a universal healthcare system, allowing the research program to focus on non-financial barriers to care. The cohort will involve serial blood sampling to evaluate antiretroviral resistance patterns, a detailed questionnaire to evaluate illicit drug use and related behaviors, and ongoing administrative linkages to the province's centralized medical care and social service databases to evaluate access to antiretrovirals and access to other HIV/AIDS care and prevention services. By helping to fill a critical information gap, this study has the potential to make a major contribution to public health policies forIDU.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
3R01DA021525-03S1
Application #
7892660
Study Section
Behavioral and Social Consequences of HIV/AIDS Study Section (BSCH)
Program Officer
Lambert, Elizabeth
Project Start
2007-09-17
Project End
2012-08-31
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
3
Fiscal Year
2009
Total Cost
$288,454
Indirect Cost
Name
University of British Columbia
Department
Type
DUNS #
251949962
City
Vancouver
State
BC
Country
Canada
Zip Code
V6 1-Z3
Reddon, Hudson; Pettes, Tyler; Wood, Evan et al. (2018) Incidence and predictors of mental health disorder diagnoses among people who inject drugs in a Canadian setting. Drug Alcohol Rev 37 Suppl 1:S285-S293
Walton, Geoffrey; Dong, Huiru; Milloy, M J et al. (2018) Increasing availability of benzodiazepines among people who inject drugs in a Canadian setting. Subst Abus 39:69-76
Jaffe, Kaitlyn; Dong, Huiru; Godefroy, Anna et al. (2018) Informal recycling, income generation and risk: Health and social harms among people who use drugs. Int J Drug Policy 60:40-46
Randhawa, Gurdeeshpal; Azarbar, Ataa; Dong, Huiru et al. (2018) Childhood Trauma and the Inability to Access Hospital Care Among People who Inject Drugs. J Trauma Stress 31:383-390
Hayashi, Kanna; Milloy, M-J; Lysyshyn, Mark et al. (2018) Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study. Drug Alcohol Depend 183:1-6
Young, Samantha; Wood, Evan; Milloy, M-J et al. (2018) Hepatitis C cascade of care among people who inject drugs in Vancouver, Canada. Subst Abus :1-8
Vipler, Sharon; Hayashi, Kanna; Milloy, M-J et al. (2018) Use of withdrawal management services among people who use illicit drugs in Vancouver, Canada. Subst Abuse Treat Prev Policy 13:27
Reddon, Hudson; Ho, Joel; DeBeck, Kora et al. (2018) Increasing diversion of methadone in Vancouver, Canada, 2005-2015. J Subst Abuse Treat 85:10-16
Klimas, Jan; Wood, Evan; Nosova, Ekaterina et al. (2018) Prevalence of Heavy Alcohol Use Among People Receiving Methadone Following Change to Methadose. Subst Use Misuse 53:270-275
Cortina, Sandra; Kennedy, Mary Clare; Dong, Huiru et al. (2018) Willingness to use an in-hospital supervised inhalation room among people who smoke crack cocaine in Vancouver, Canada. Drug Alcohol Rev 37:645-652

Showing the most recent 10 out of 183 publications